Navigation Links
Lincare Holdings Inc. Announces First Quarter 2008 Financial Results
Date:4/21/2008

ity of appropriate acquisition candidates and Lincare's ability to successfully complete and integrate acquisitions, efficient operation of Lincare's existing and future operating facilities, regulation and/or regulatory action affecting Lincare or its business, economic and competitive conditions, access to borrowed and/or equity capital on favorable terms and other risks described in the filings of Lincare with the Securities and Exchange Commission.

In developing its forward-looking statements, Lincare has made certain assumptions relating to reimbursement rates and policies, internal growth and acquisitions and the outcome of various legal and regulatory proceedings. If the assumptions used by Lincare differ materially from what actually occurs, then actual results could vary significantly from the performance projected in the forward-looking statements. Lincare is under no duty to update any of the forward-looking statements after the date of this release.

LINCARE HOLDINGS INC.

Financial Summary

(Unaudited)

(In thousands, except share and per share data)

For the three months ended

March 31, March 31,

2008 2007

Net revenues $415,420 $378,459

Costs and expenses:

Costs of goods and services 97,587 88,134

Operating expenses 96,278 91,884

Selling, general and administrative

expenses 82,195 76,367

Bad debt expense 6,231 5,677

Depreciation expense 29,509 25,901

Amo
'/>"/>

SOURCE Lincare Holdings Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2007 Financial Results
2. Lincare Holdings Inc. Prices $500 Million Convertible Senior Debentures Offering
3. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
4. Lincare Holdings Inc. Announces Fourth Quarter and Year Ended 2007 Financial Results
5. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
6. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
9. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
10. Platinum Underwriters Holdings, Ltd. to Report Third Quarter 2007 Results on October 23, 2007
11. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 1Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 2Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 3Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 4Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 5Stimulus Funds Establish Seattle as Hub of Comparative Effectiveness Research in Cancer 59238 6Torrids Model Search Winners Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 59235 1Torrids Model Search Winners Celebrities Celebrate Fashion and Help Support the National Breast Cancer Foundation at the House of Dreams Event 59235 2MDMA Board Unanimously Opposes Medical Device Tax 5366 1MDMA Board Unanimously Opposes Medical Device Tax 5366 2